What is NDC 0409-6482?

0409-6482 is the product NDC for Erythrocin Lactobionate (erythromycin lactobionate), Erythromycin lactobionate 500 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Erythrocin Lactobionate (Erythromycin lactobionate).

Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Erythrocin Lactobionate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Erythrocin Lactobionate NDC 0409-6482

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-6482Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-6482Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-6482-01	0040964820100409648201	10 VIAL in 1 TRAY (0409-6482-01) / 10 mL in 1 VIAL (0409-6482-11)Marketed from May 25, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Erythrocin Lactobionate
Generic name (nonproprietary): erythromycin lactobionate
Active ingredients: Erythromycin lactobionate — 500 mg/10mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Hospira, Inc.NDC labeler code 0409
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 050609
Marketing start: May 25, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 0409-6482_129ba067-a214-45c6-8c39-cafc82a32546SPL ID 129ba067-a214-45c6-8c39-cafc82a32546SPL set ID a96c405f-bd70-4bb4-719e-ac6a79dcc213RxCUI 1668264, 1668267UNII 33H58I7GLQ
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409648201 followed by a unit qualifier and the quantity

Package 00409-6482-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Erythrocin Lactobionate-IV (erythromycin lactobionate for injection, USP) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. Intravenous therapy should be replaced by oral administration at the appropriate time. Upper respiratory tract infections of mild to moderate degree caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci); Streptococcus pneumoniae (Diplococcus pneumoniae); Haemophilus influenzae (when used concomitantly with adequate doses …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0409-6482

What is NDC 0409-6482?: 0409-6482 is the product NDC for Erythrocin Lactobionate (erythromycin lactobionate), Erythromycin lactobionate 500 mg/10mL injection, powder, lyophilized, for solution, listed with the FDA by Hospira, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Erythrocin Lactobionate (Erythromycin lactobionate).
What is the active ingredient?: Erythromycin lactobionate.
Who is the labeler?: Hospira, Inc., NDC labeler code 0409. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Erythrocin Lactobionate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Erythrocin Lactobionate (Erythromycin lactobionate) NDC 0409-6482